Peptide Stacks · Exact presentation
PT-141 + Melanotan II · 10 mg + 10 mg Stack
PT-141 + Melanotan II · 10 mg + 10 mg Stack describes separate products coordinated in one research reference. It does not represent a single-vial blend.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
PT-141 & Melanotan II (10 mg Vials) Dosage Protocol
The source chart summarizes “750 mcg–1.75 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Dosing & Reconstitution Guide
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 3.33 mg/mL. It must be checked against the actual formulation and documentation.
PT-141 (Bremelanotide) — On-Demand Protocol (3 mL = ~3.33 mg/mL)
The source chart summarizes “750 mcg–1.75 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
PT-141 (Bremelanotide) — On-Demand Protocol (3 mL = ~3.33 mg/mL)
| Phase | Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Initial / Titration | 500–750 mcg | 15–22 units (0.15–0.22 mL) |
| Standard | 1000–1500 mcg | 30–45 units (0.30–0.45 mL) |
| Full / FDA-Approved | 1750 mcg (1.75 mg) | 52 units (0.52 mL) |
Melanotan II — Daily Protocol (3 mL = ~3.33 mg/mL)
The source chart summarizes “750 mcg–1.75 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Melanotan II — Daily Protocol (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 250 mcg | 7.5 units (0.075 mL)* |
| Week 2 | 500 mcg | 15 units (0.15 mL) |
| Weeks 3–4 | 750 mcg | 22 units (0.22 mL) |
| Weeks 5+ (Loading) | 1000 mcg | 30 units (0.30 mL) |
| Maintenance | 500–1000 mcg (2–3×/week) | 15–30 units (0.15–0.30 mL) |
Reconstitution Steps (Both Peptides)
No reconstitution extrapolation is published because the unit, formulation, or composition does not support one reliable calculation from the source inventory. Reference concentration stated by the source: 3.33 mg/mL. It must be checked against the actual formulation and documentation.
PT-141 (On-Demand, ~1×/week)
PT-141 + Melanotan II · 10 mg + 10 mg Stack describes separate products coordinated in one research reference. It does not represent a single-vial blend.
Melanotan II (Daily Loading → Maintenance)
PT-141 + Melanotan II · 10 mg + 10 mg Stack describes separate products coordinated in one research reference. It does not represent a single-vial blend.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How These Peptides Work
The proposed mechanism depends on the molecular identity and receptor systems described in the literature. A mechanism alone does not establish clinical efficacy.
Potential Benefits & Side Effects
Identity, purity, sterility, stability, and equivalence to studied products cannot be assumed. Adverse effects and interactions may be incompletely characterized.
PT-141
PT-141 + Melanotan II · 10 mg + 10 mg Stack describes separate products coordinated in one research reference. It does not represent a single-vial blend.
Melanotan II
PT-141 + Melanotan II · 10 mg + 10 mg Stack describes separate products coordinated in one research reference. It does not represent a single-vial blend.
Source trail
Scientific references and source discovery
- PeptideDosages — exact PT-141 + Melanotan II · 10 mg + 10 mg Stack entrysecondary-structure
- PubMed — literature search for PT-141 + Melanotan IIprimary-discovery
- ClinicalTrials.gov — study search for PT-141 + Melanotan IItrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference